Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB1740

Introduced
2/5/24  
Refer
2/6/24  
Report Pass
2/15/24  
Engrossed
3/6/24  
Refer
3/25/24  
Report Pass
3/27/24  
Enrolled
4/17/24  

Caption

Substance abuse services; clarifying applicability of certain liability protections; broadening the Good Samaritan Act. Emergency.

Impact

The bill modifies current statutes concerning substance abuse services by clarifying terminology and expanding the scope of liability protections for individuals administering emergency medications. By allowing first responders, which include law enforcement and emergency medical personnel, to provide opioid antagonists without a prescription, the legislation directly aims to reduce the number of overdose fatalities. Furthermore, the amendments are designed to promote a more proactive approach to handling opioid overdoses in various community settings, including schools and public venues.

Summary

Senate Bill 1740 aims to enhance the administration of emergency opioid antagonists, specifically naloxone, in response to the ongoing opioid crisis. The bill strengthens the existing Good Samaritan Act by broadening the applicability of certain liability protections for individuals administering these life-saving drugs during emergencies. This includes not only healthcare professionals but also family members and other bystanders who may encounter someone experiencing an opioid overdose, thereby encouraging timely intervention without the fear of legal repercussions.

Sentiment

The sentiment around SB 1740 has been largely positive, as supporters argue that the enhancements to the Good Samaritan Act will save lives by encouraging more people to act in emergencies involving opioid overdoses. Public health advocates and stakeholders in the substance abuse treatment community have praised the bill for addressing critical gaps in the existing laws that may have previously discouraged bystanders from intervening. However, there are voices of caution regarding the reliance on bystanders for emergency care and the need for ongoing public health education to complement the legislation.

Contention

While there is strong support for SB 1740, there are concerns about ensuring that individuals receiving naloxone administration are properly educated on recognizing overdose symptoms and the correct method of administering the drug. Critics emphasize that while liability protections are essential, training and education remain crucial components in effective emergency response. The balance between encouraging intervention and ensuring adequate training for those administering lifesaving measures forms a key point of contention as the bill moves through the legislative process.

Companion Bills

No companion bills found.

Similar Bills

HI HB310

Relating To Opioid Antagonists.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

MS SB2336

Prevention of overdoses; authorize administration of opioid antagonists by certain persons, provide immunity to.

MS SB2442

Emergency Response and Overdose Prevention Act; amend to expand the distribution and use of opioid antagonists.

MI HB5077

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106.

MI HB4366

Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: HB 4365'23

CA SB472

Pupil health: opioid overdose reversal medication.

MS HB1137

Opioid antagonists; authorize community organizations and others to receive and administer.